COVID-19 studies for: C19 studies:  HC QHC Q IvermectinIVM Vitamin DVitamin D ZincZn REGN-COV2REGN LY-CoVLY RemdesivirRMD
HC Q study #161
Source   PDF   Share   Tweet
See all 181 studies
Early treatment study
Fonseca et al., Travel Medicine and Infectious Disease, doi:10.1016/j.tmaid.2020.101906 (Peer Reviewed)
Risk of Hospitalization for Covid-19 Outpatients Treated with Various Drug Regimens in Brazil: Comparative Analysis
64% lower hospitalization with HC Q. Retrospective 717 patients in Brazil with early treatment, adjusted OR 0.32, p=0.00081, for HC Q versus no medication, and OR 0.45, p=0.0065, for HC Q vs. anything else.
hospitalization, ↓64.0%, p=0.0008, HCQ vs. nothing
hospitalization, ↓50.5%, p=0.006, HCQ vs. anything else
(odds ratio converted to relative risk)
Source   PDF   Share   Tweet
See all 181 studies
Please send us corrections, updates, or comments.